Together, the results indicate that TGFβ1, in addition to its capacity to induce EMT in breast cancer cells, can act on lymphatic endothelial cells to promote the expression of factors, which are chemotactic for breast cancer cells with mesenchymal properties (Fig. 7). This evidence concerns the gene TGFB1 and breast carcinoma.